Access cutting-edge end-stage renal disease treatment through this clinical trial at a research site in Jacksonville. Study-provided care at no cost to qualified participants.
Access end-stage renal disease specialists in Jacksonville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related end-stage renal disease treatment provided free
The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months in patients with end-stage renal disease (ESRD) needing hemodialysis (HD). Participants will be stratified by location of the vascular access (forearm versus upper arm) and by type of AVF creation procedure planned by the surgeon at randomization (1-stage AVF versus 2-stage AVF). The comparator is
Sponsor: Humacyte, Inc.
Check if you qualify for this end-stage renal disease clinical trial in Jacksonville, FL
If you're searching for end-stage renal disease treatment options in Jacksonville, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jacksonville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end-stage renal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.